Use of the wearable cardioverter-defibrillator – the Swiss experienceBoldizsar Kovacs, Fırat Duru, Urs Eriksson et al.|Swiss Medical Weekly|2020Cited by 14
Extended Use of the Wearable Cardioverter-Defibrillator: Which Patients Are Most Likely to Benefit?Boldizsar Kovacs, Fırat Duru, Urs Eriksson et al.|Cardiology Research and Practice|2018Cited by 10
Medical therapy with flecainide and propafenone in atrial fibrillation: Long-term clinical experience in the tertiary care settingBoldizsar Kovacs, Fırat Duru, Urs Eriksson et al.|Cardiology Journal|2022Cited by 9
Outcomes during and after the use of the wearable cardioverter-defibrillator in a tertiary-care and a regional hospital in SwitzerlandBoldizsar Kovacs, Fırat Duru, Urs Eriksson et al.|Swiss Medical Weekly|2019Cited by 6
Wearable Cardioverter–Defibrillator-Measured Step Count for the Surveillance of Physical Fitness during Cardiac RehabilitationBoldizsar Kovacs, Matthias Hermann, David Niederseer et al.|Sensors|2021Cited by 6